Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.G Ambrosini, P. Marsilio, Enrico Capodicasa et al.|Journal of Clinical Oncology|1988Cited by 168
Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and CyclophosphamidePaola Papaldo, F. Calabresi, Massimo Lopez et al.|Journal of Clinical Oncology|2005Cited by 96
Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and CyclophosphamidePaola Papaldo, Paolo Marolla, Massimo Lopez et al.|Journal of Clinical Oncology|2003Cited by 76
Hormonal Treatment of Disseminated Male Breast CancerMassimo Lopez, Paola Papaldo, Luigi Di Lauro et al.|Oncology|2009Cited by 57
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcomePatrizia Vici, Filippo Montemurro, Daniele Santini et al.|Oncotarget|2016Cited by 43